Liposarcoma future or investigational therapies: Difference between revisions
No edit summary |
|||
| Line 20: | Line 20: | ||
It involves drugs already approved by US FDA (Food and Drug administration) for atleast one disease. | It involves drugs already approved by US FDA (Food and Drug administration) for atleast one disease. | ||
===SARC trials<ref name=SARC>{{cite web | title = SARC trials | url = http://www.sarctrials.org/sarc-clinical-trials }}</ref> | ===SARC trials=== | ||
Clinical trails are being conducted by SARC on soft tissue tumors as a part of furute investigationa therapies.<ref name=SARC>{{cite web | title = SARC trials | url = http://www.sarctrials.org/sarc-clinical-trials }}</ref> | |||
==References== | ==References== | ||
Revision as of 05:40, 22 September 2014
|
Liposarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Liposarcoma future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Liposarcoma future or investigational therapies |
|
Risk calculators and risk factors for Liposarcoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Clinical trials
Tests and treatment go through four different phases of clinical trail to test the benefits of it. The four phases of treatment are as follows.[1]
- Phase 1 trial
It aims to find out the best dose of a new drug with the lowest side effects
- Phase 2 trial
Asses whether a drug works for a specific cancer or not
- Phase 3 trial
Compares a new drug to a standard treatment
- Phase 4 trail
It involves drugs already approved by US FDA (Food and Drug administration) for atleast one disease.
SARC trials
Clinical trails are being conducted by SARC on soft tissue tumors as a part of furute investigationa therapies.[2]